AI-generated summary
The authors tested verteporfin combined with nonthermal laser light on human corneas outside the body, comparing it with standard riboflavin and UVA treatment. They report that six laser sequences with verteporfin made the corneas stiffer and more resistant to enzymatic degradation, with changes similar to standard cross-linking. The study used only five corneas per group and was ex vivo, so the authors state that a clinical study is needed.
- Who or what was studied
- Thirty human corneas, five per group, tested ex vivo
- Wavelengths
- 689, 370 nm
- Limits stated in the abstract
- The study was ex vivo with only five corneas per group, and the authors state that a clinical study is needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 689 nm, 370 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Ultraviolet, Irradiance, Collagen. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.